Type 2 & other diabetes

Novel Automated Self-adjusting Subcutaneous Insulin Algorithm Improves Glycemic Control and Physician Efficiency in Hospitalized Patients

J Diabetes Sci TechnolPublished Retrospective cross-sectional study

Authors' conclusion

The SQIA reduced severe hyperglycemia, hypoglycemia, and severe hypoglycemia compared with conventional insulin dosing. It also improved physician efficiency by reducing the number of order modifications a physician had to place.

Study context

Population
Hospitalized patients on nil per os, continuous total parenteral nutrition or continuous tube feeding, University of California San Francisco hospitals, September 2020–September 2021
Exposure
Automated self-adjusting subcutaneous insulin algorithm (SQIA) vs conventional, physician-driven insulin dosing
Outcome
Proportion of glucose in range (70-180 mg/dL)

Main finding

As reported in the abstract

P = 0.153

Observational data: associations, not effects.

Further findings

Severe hyperglycemia (>250 mg/dL) events

P = 0.017

Physician efficiency: insulin orders placed or modified

Number of orders a physician had to place reduced with SQIA vs conventional dosing by a factor of
more than 12

Safety

Hypoglycemia (54-69 mg/dL) events

P = 0.029

Severe hypoglycemia (<54 mg/dL) events

P = 0.076

Original publication

Novel Automated Self-adjusting Subcutaneous Insulin Algorithm Improves Glycemic Control and Physician Efficiency in Hospitalized Patients. J Diabetes Sci Technol. Published 7 March 2024. doi:10.1177/19322968241232673

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.